Ensuring Virtual Vigilance in Decentralized Clinical Trials

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

Untapped Potential? Representativeness in Pragmatic Clinical Trials

Inappropriate antibiotic prescription for acute tonsillitis in low- and middle-income countries (LMICs): a systematic review and meta-analysis protocol

Evaluation of tolvaptan-associated hepatic disorder using different national pharmacovigilance databases

Informing the risk assessment related to lactation and drug exposure: A physiologically based pharmacokinetic lactation model for pregabalin

Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database

A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617

Machine learning driven bioequivalence risk assessment at an early stage of generic drug development

Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system

Ginkgo biloba extract safety: Insights from a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events

Knowledge, Attitude, and Practice Regarding Pharmacovigilance and Barriers to Reporting Adverse Drug Reactions Among the General Population in Saudi Arabia

Lichenoid Drug Eruption Secondary to Systemic Antibiotics: Case Report

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Pharmacovigilance monitoring and treatment adherence in patients on antihypertensive drugs at a tertiary care centre

Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis

Uma breve revisão sobre Farmacovigilância: histórico, conceitos, aplicações e resoluções norteadoras

Adverse Drug Reactions to β-Lactam Antibiotics: A Portuguese Pharmacovigilance Database Analysis

Exploring drug-induced toxic epidermal necrolysis: A case series and comprehensive review

Posición de la Academia Nacional de Medicina respecto a la disposición de la ANMAT que cataloga a los inhibidores de la bomba de protones (IBP) como de “venta libre”

Developing a Screening Strategy to Identify Hepatotoxicity and Drug Interaction Potential of Botanicals

Exploring the influencing factors of adverse drug reaction reporting among medical personnel: a COM-B model-based study

Exploring Human Misuse and Abuse of Veterinary Drugs: A Descriptive Pharmacovigilance Analysis Utilising the Food and Drug Administration’s Adverse Events Reporting System (FAERS)

The Food and Drug Administration's Safety Surveillance of Adverse Event Cases Involving Cannabinoid Hemp Products, 2019–2023

Influence of inpatient withdrawal treatment on drug safety in alcohol use disorder — a quasi-experimental pre-post study

Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a real-world analysis from FAERS database

Can Pharmacovigilance Data Represent a Potential Tool for Early Detection of the Antibiotic Resistance Phenomenon?

Practices and awareness of pharmacovigilance in ALERT hospital, Addis Ababa, Ethiopia, a pilot study

General selection criteria for safety and patient benefit [XⅢ]: Comparing the formulation characteristics of brand-name and generic bifonazole creams

Comparative safety of different antibiotic regimens for the treatment of outpatient community-acquired pneumonia among otherwise healthy adults

Evaluating the impact of loperamide on irinotecan-induced adverse events: a disproportionality analysis of data from the World Health Organization pharmacovigilance database (VigiBase)

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine

ASSESMENT OF ATTITUDE AND PRACTICE TOWARDS ADVERSE DRUG REACTION REPORTING OF HEALTH PROFESSIONALS IN REPUBLIC OF NORTH MACEDONIA

Educate to Reduce Unnecessary Antibiotic Prescriptions

Using digital health technologies to optimise antimicrobial use globally

How Will Trump’s Government Impact Health Policy Abroad?

El PRAN celebra 10 años de retos y logros en su jornada anual por el Día Europeo para el Uso Prudente de los Antibióticos

Machine learning algorithms for prediction of measles one vaccination dropout among 12–23 months children in Ethiopia

Reassuring Data on GLP-1 RAs and Pancreatic Cancer Risk

FDA Updates GLP-1 Label With Pulmonary Aspiration Warning

First Trimester Tetracycline Exposure and Risk of Major Congenital Malformations

Collaborative Real-World Evidence Among Regulators: Lessons and Perspectives

Cardiovascular adverse events associated with triptans for treatment of migraine: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)

DNA-Based Chemical Unclonable Functions for Cryptographic Anticounterfeit Tagging of Pharmaceuticals

Pharmacovigilance: the evolution of drug safety monitoring

Adverse drug reactions following treatment of latent tuberculosis infection: a linked national tuberculosis surveillance with claims database

Nirsevimab Resistance Mutations Rare in RSV, Study Shows

Does Antibiotic Use During Influenza Infection Worsen Lung Immunity?

Papel del Servicio de Seguimiento Farmacoterapéutico (SFT) de la farmacia comunitaria en la detección y resolución de reacciones adversas a estatinas vinculadas a posibles errores diagnósticos en pacientes mayores

Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023

Trends of drug shortages in China from 2018 to 2020: A retrospective observational study

Evaluation of β-Blocker-Induced Bradyarrhythmia Using an Analysis of the Japanese Adverse Drug Event Report Database

Cardiovascular adverse events associated with norepinephrine–dopamine reuptake inhibitors: a pharmacovigilance study of the FDA Adverse Event Reporting System

Causal Deep Learning for the Detection of Adverse Drug Reactions: Drug-Induced Acute Kidney Injury as a Case Study

Gabapentinoids and Risk of Hip Fracture

Argus Database Software: Revolutionizing Drug Safety and Pharmacovigilance

Digitalisation of Monitoring Side Effects Before, During and After COVID-19 Vaccines–Analysis of the Impact of the Pandemic on Reporting Side Effects in Republic of Croatia

Meta Analysis of Efficacy and Safety of Traditional Chinese Medicine Combined with Immunosuppressive Agents in the Treatment of IgA Nephropathy

Mutagenicity and genotoxicity evaluation of 15 nitrosamine drug substance-related impurities in human TK6 cells

Sex Differences of Fall-Risk-Increasing Drugs in the Middle-Aged and Elderly: A Pharmacovigilance Analysis of FDA Adverse Event Reporting System

Statistics and Studies on the Impact of Ineffective Medications in Patients

Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial

Strategies to Help Patients Navigate High Prescription Drug Costs

The Impact of Cyberethics on Healthcare and Public Health Sector

A Clustering Ensemble Method for Drug Safety Signal Detection in Post-Marketing Surveillance

Securing Drug Traceability: Block chain-Enhanced Privacy Protection and Anti-Counterfeit Measures in Pharmaceutical Supply Chains

Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals

Las XIII Jornadas Nacionales de Farmacovigilancia celebradas por la AEMPS reúnen a más de 500 profesionales sanitarios

Use of real-world data sources to evaluate cancer treatments: current practice and future perspectives

A Prospective Study of the Medication Regimen Complexity Index and Hospitalization Due to Adverse Drug Reactions Among People Living with HIV

Global Differences and Risk Factors Influencing Drug Hypersensitivity Quality of Life: A Multi-Centre, Multi-ethnic Study of Drug Allergy Across Three Continents

Prevalence and factors associated with preventable drug-related emergency department visits (DREDp) in elderly patients

Seguridad de enantato de noretisterona y valerato de estradiol como método anticonceptivo en Perú

Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database

Combating Misinformation on Social Media Using Social Noise and Social Entropy as a Measure of Uncertainty

SURVEY OF KNOWLEDGE OF PHARMACOVIGILANCE AND ADVERSE DRUG REACTIONS REPORTING AMONG HEALTHCARE PROVIDERS IN ABUJA, NIGERIA

Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis

A study on user willingness to participate in an adverse drug event information sharing system

A real-world pharmacovigilance study of Ocrelizumab based on FAERS database

Adverse events associated with Tezepelumab: a safety analysis of clinical trials and a pharmacovigilance system

Quantification of the prevalence of harms in healthcare related to drug treatment: reflections regarding the use of definitions developed for other settings to estimate the magnitude of the problem

Exploration of the potential association between newer antiseizure medications and arrhythmias: Integrating pharmacovigilance and bioinformatics evidence

Retrospective Evaluation of the Prevalence and Drug Susceptibility of Candida Species and an Analysis of Risk Factors for Oral Candidiasis

Impact of educational intervention on sensitisation and ADR reporting among paramedics in a teaching hospital in north India

Diabetic adverse events associated with three commonly used statins: a disproportionality analysis based on the FDA adverse event reporting system database

Insights into Fracture Risk with Tenofovir and Entecavir: Evidence from Pharmacovigilance Data

FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine

Methylphenidate and Atomoxetine in Pregnancy and Possible Adverse Fetal Outcomes. A Systematic Review and Meta-Analysis

Doctors Caution Over Weight Loss Drug Link to Nurse's Death

UN Meeting Highlights Antimicrobial Resistance “Epiphany”—Lack of Antibiotic Access Is a Key Driver

Boletín sobre Seguridad de Medicamentos de Uso Humano. Septiembre de 2024

Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines. A Randomized Clinical Trial

La AEMPS recuerda las condiciones necesarias para la donación de medicamentos en las zonas afectadas por la DANA

Pharmacy Closures and Anticonvulsant Medication Prescription Fills

GLP-1 RAs Safe in the Perioperative Period: New Guidance

Neonatal Colonization With Antibiotic-Resistant Pathogens in Low- and Middle-Income Countries. A Systematic Review and Meta-Analysis

Explainable artificial intelligence (XAI) to find optimal in-silico biomarkers for cardiac drug toxicity evaluation

Online Marketing of Falsified Drugs in Ghana: Content Analysis of Selected Drugs on Social Media

DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction

Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition

Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis

Diagnosing and Treating ADHD in Adults. Balancing Individual Benefits and Population Risks

High-Risk Medications in Persons Living With Dementia. A Randomized Clinical Trial

Analysis on Innovation and Application of Anti-counterfeiting Technology of Printed Matter

Trends in Antidiabetic Drug Use and Safety of Metformin in Diabetic Patients with Varying Degrees of Chronic Kidney Disease from 2010 to 2021 in Korea: Retrospective Cohort Study Using the Common Data Model

Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine

Knowledge attitude and practice of pharmacovigilance among community pharmacy in India: a questionnaire study

Curcuma-Based Nutritional Supplements and Risk of Age-Related Macular Degeneration

Drug-induced myocarditis: a real-world pharmacovigilance study using the FDA adverse event reporting system database

Acute toxicity and anti-inflammatory activity of an improved traditional medicine developed in Burkina Faso

Risk of Inflammatory Central Nervous System Diseases After Tumor Necrosis Factor–Inhibitor Treatment for Autoimmune Diseases. A Systematic Review and Meta-Analysis

Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis. Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks

Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databases

Analysis of rational prescription of medicines by village clinics: a repeated cross-sectional study of a province in eastern China

Inhaled Reliever Therapies for Asthma. A Systematic Review and Meta-Analysis

La AEMPS lanza la campaña #EsPopularPeroNoCiencia frente a las seudoterapias

FDA Okays Abuse-Deterrent Opioid for Severe Pain

Michigan Oncologist Charged in Scheme to Illegally Sell Cancer Drugs

Outpatient Antibiotic Use and Treatment Failure Among Children With Pneumonia

Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 Diabetes

The African Medicines Agency and Medicines Regulation: Progress, challenges, and recommendations

Substance Use Disorders Crisis Intervention Training (CIT)

Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis

Establishing a multi‐method approach for unprecedented detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban drug substance through ultra-performance liquid chromatography (UPLC)

ENSURING DRUG SAFETY: A REVIEW OF PHARMACEUTICAL QUALITY ASSURANCE PRACTICES

Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database

Reducing Errors and Enhancing Efficiency: The Role of IoT in Automating Pharmaceutical Supply Chains

Risk factors and drug resistance of adult community-onset urinary tract infections caused by Escherichia coli-producing extended-spectrum β-lactamase in the Chongqing region, China: a retrospective case–control study

Improving patient safety and access to healthcare: The role of pharmacist-managed clinics in optimizing therapeutic outcomes

State Policies Regulating Law Enforcement Access to Prescription Drug Monitoring Program Testosterone Prescription Data

THE ROLE OF E-PRESCRIBING IN IMPROVING THE SAFETY AND ACCURACY OF DRUG PRESCRIPTIONS

Low-Dose Aspirin and Risk of Anaemia in Older Adults: Insights from a Danish Register-based Cohort Study

Estrategias de la vigilancia de los eventos adversos a la inmunización contra la COVID-19: Experiencia cubana

A cross-sectional study to determine the potential drug–drug interactions in patients with alcoholic liver disease in a tertiary care hospital

The Importance of Pharmacovigilance in the Polyherbal Sector: Challenges and Future Potential

Leveraging Real-World Evidence in Pharmacovigilance Reporting

Deep neural network-based detection of counterfeit products from smartphone images

Identifying and quantifying exposures involving counterfeit opioid analgesic products

Prediction of adverse drug reactions using demographic and non-clinical drug characteristics in FAERS data

Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa

Adverse Drug Events by Sex After Adjusting for Baseline Rates of Drug Use

Perspective Chapter: Challenges and Possible Solutions of ADR Monitoring (Pharmacovigilance) in Low- and Middle-Income Countries

Misinformation about Sunscreens on Brazilian Social Networks: A Risk to Public Health

Therapeutic drug monitoring of linezolid in Chinese premature neonates: a population pharmacokinetic analysis and dosage optimization

Evaluation of drug-related problems identified and pharmaceutical interventions in the wards of a maternity hospital

Pancreatitis inducidas por fármacos: estudio de 38 pacientes

Adverse Event Profile Differences among Long-acting Gonadotropin-releasing hormone analogs: A Real-world, Pharmacovigilance Study

Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis

FDA Announces Recall of More than 7000 Bottles of Duloxetine

La AEMPS anuncia los ganadores de la IV edición de los premios del Plan Nacional frente a la Resistencia a los Antibióticos

EU Program Aims to Ensure Safety for Pilots Who Use Insulin

Increasingly Popular Hormonal Contraceptive Linked to Breast Cancer

Exploring the community pharmacist's knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Association between Polypharmacy and Adverse Events in Patients with Alzheimer’s Disease: An Analysis of the Japanese Adverse Drug Event Report Database (JADER)

Can Vaccines Slash Global Antibiotic Use? WHO Says Yes

Comparison of the efficacy and safety of low-dose antihypertensive combinations in patients with hypertension: protocol for a systematic review and network meta-analysis

Cognitive Decline and Antihypertensive Use: New Data

Global and Regional Burden of Vaccine-Associated Erythema Multiforme and their Related Vaccines, 1967–2023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database

Adverse reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS

Implementation Status and Challenges of Pharmacovigilance Program in Ethiopia: A Mixed-Methods Study

From Risk to Resilience: Uncovering Drug Recall Trends and Bolstering Safety Strategies

Exploring willingness to use adverse drug reaction reporting systems: a multicentre qualitative study in China based on the technology acceptance model and task-technology fit integration approach

Disproportionality analysis of reslizumab based on the FDA Adverse Event Reporting System

Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019–2021)

Post-marketing safety concerns with rimegepant based on a pharmacovigilance study

Real-World Assessment of Psychotropic and Antiepileptic Drug Use During Pregnancy in Belgium: Trends, Predictors, and Comparative Risk of Congenital Anomalies (2010–2016)

¿Es hora de reconsiderar el uso prolongado de betabloqueantes tras un infarto?

For Bloodstream Infection, 7 Days of Antibiotics as Effective as 14

Algorithmovigilance, lessons from pharmacovigilance

Isotretinoin and Suicide: Data Mining of the United States Food and Drug Administration Adverse Event Reporting System Database

Adequacy of Pharmacovigilance Training in the Health Professional Training Institutions in Uganda: Training Gaps and Opportunities for Improvement

When Patient Voices Get Lost in Evidence Hierarchies: A Testimony of Rare Adverse Events and Participatory Epistemic Injustice in Drug Safety Monitoring

Time to major adverse drug reactions and its predictors among children on antiretroviral treatment at northwest Amhara selected public hospitals northwest; Ethiopia, 2023

“Before medically advised” hospital discharge and the risk of subsequent drug overdose: A case‐crossover analysis

Adverse Drug Reactions in an Ageing PopulaTion risk Prediction (ADAPTiP) tool: development of a prediction model related to hospital admissions

Pharmaceutical Logistics under Cyberattack Conditions

Social Media Exposure to Health Misinformation and Effect on Vaccination Intention and Behaviour

Enhancing medication errors detection and reporting through online learning Can an online course make a difference?

Efficacy and safety of higher dose rifampicin in adults with presumed drug-susceptible tuberculosis: an updated systematic review and meta-analysis

Safety assessment of drug impurities for patient safety: A comprehensive review

Efficacy and safety of vancomycin compared with those of alternative treatments for methicillin‐resistant Staphylococcus aureus infections: An umbrella review

Racial representation in multicenter clinical trials leading to drug approvals for gynecological cancer indications by the US Food and Drug Administration (FDA).

Comprehensive analysis of VEGF/VEGFR inhibitor-induced immune-mediated hypertension: integrating pharmacovigilance, clinical data, and preclinical models

MDDC: An R and Python Package for Adverse Event Identification in Pharmacovigilance Data

Safety challenges of AI in medicine

Artificial intelligence-powered chatbots in search engines: a cross-sectional study on the quality and risks of drug information for patients

A Concise Review on 3-D Printing Technology in Pharmaceutical Sciences

FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine

World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Participants

Declaration of Helsinki Addresses New Ethical Challenges

The 2024 Revision to the Declaration of Helsinki. Modern Ethics for Medical Research

Revisiting the Declaration of Helsinki—A Patient-Centered Perspective

Facilitating Efficient and Ethical Trials at the Intersection of Research and Clinical Care

The Revised Declaration of Helsinki—Considerations for the Future of Artificial Intelligence in Health and Medical Research

The Revision of the Declaration of Helsinki Viewed From the Americas—Paving the Way to Better Research

Future-Proofing Research Ethics—Key Revisions of the Declaration of Helsinki 2024

Revisions to the Declaration of Helsinki on Its 60th Anniversary. A Modernized Set of Ethical Principles to Promote and Ensure Respect for Participants in a Rapidly Innovating Medical Research Ecosystem

Making the Ethical Oversight of All Clinical Trials Fit for Purpose

Risk of Suicidal Ideation or Attempts in Adolescents With Obesity Treated With GLP1 Receptor Agonists

Antipsychotic Drugs and Cognitive Function. A Systematic Review and Pairwise Network Meta-Analysis

The Hidden Cost of Cancer Treatment: Time Toxicity

Use of Opioid Overdose Reversal Drug by Community Still Small Portion of Total Naloxone Administrations

Riding the waves of uncertainty: Towards strategic agility in medicine supply systems

The significance of therapeutic drug monitoring in detecting low medication adherence in patients with cancer: A case study of cabozantinib

Why a Diabetes Drug Fell Short of Anticancer Hopes

Adverse Effects and Contraindications of Sodium Bicarbonate Treatment

The Flu Vaccine Might Be Less Effective This Year

Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine

Public Health and Online Misinformation

La banalidad de la mentira. Su relación con la práctica médica

Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer

The Application of Machine Learning in Drug Discovery

Postmarketing adverse events of tamoxifen in male and female patients with breast cancer

The Role of AI in Combating Counterfeit Drugs

Developing large language models to detect adverse drug events in posts on x

Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study

A critical need for ‘gut neutrality’: mitigating adverse drug–microbiome interactions

Las empleadas de la dependencia que soportan la precariedad a base de opioides: "La gente está agotada, quemada"

Taxonomía de la seguridad del paciente

Remedies for Menopause Symptoms Show Short-Term Benefit, Need Long-Term Data

Knowledge, attitudes, and practices of hospital pharmacists regarding clinically relevant drug interactions: A multi-center regional survey in Indonesia.

Antiseizure Medications and Cardiovascular Events in Older People With Epilepsy

Myth of the Month: Vitamin C vs the Common Cold

Adverse Drug Reactions in Psychiatry: An Alarming Scenario

Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System

Botanical-induced toxicity: Liver injury and botanical-drug interactions. A report on a society of Toxicology Annual Meeting symposium

Incidence of Adverse Events Related to Therapies with sodium iodine (131I): Contribution to the Pharmacovigilance in Brazil

The Hidden Risks of Using Counterfeit Drugs

Adverse Drug Reactions During Intensive Phase of Treatment Among Multi-Drug Resistant Tuberculosis Cases Registered at a DR-TB Centre of Southern India

Suspected poor-quality medicines in Kenya: a retrospective descriptive study of medicine quality-related complaints reports in Kenya’s pharmacovigilance database

ADVERSE DRUG REACTION DUE TO COMBINATION OF AMOXICILLIN AND CLAVULANIC ACID ALONG WITH ITS CAUSALITY ASSESSMENT: A CASE REPORT

'Deb's Active Surveillance & Assisted Reporting System: A District Based Innovative Approach to Adverse Drug Reaction Monitoring

Evaluating Medical Students' Knowledge, Attitudes, and Practices in Pharmacovigilance: A Cross-Sectional Study

Safety and Efficacy of Drug-Eluting Stents Improved Dramatically with Application of Nanotechnology

Delayed drug hypersensitivity reactions: How p-i transforms pharmacology into immunology

Association of anxiolytic drugs with Torsade de Pointes: a pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System

Drug-Related Keratitis: A Real-World FDA Adverse Event Reporting System Database Study

Adverse Drug Reactions Resulting From the Use of Chiral Medicines Amoxicillin, Amoxicillin-Clavulanic Acid, and Ceftriaxone: A Mixed Prospective-Retrospective Cohort Study

The Proliferation And Impact Of Clandestine Drug Laboratories In India

Health risk assessment of heavy metals in Malay herbal medicine (MHM) consumed by pregnant and postpartum mothers

Antibiotics-induced pulmonary embolism: A disproportionality analysis in Food and Drug Administration database of Adverse Event Reporting System using data mining algorithms

Self-Reported Illicitly Manufactured Fentanyl Use and Associated Health and Substance Use Risks in the United States, 2022

High Drug Costs Influence Nonadherence to Medications Among Older Adults

Interpretable multitemporal liver function indicator model for prediction and risk factor analysis of drug induced liver injury

Stratified analysis of the association between anti-obesity medications and digestive adverse events: a real-world study based on the FDA adverse event reporting system database

High-risks drug adverse events associated with Cetirizine and Loratadine for the treatment of allergic diseases: A retrospective pharmacovigilance study based on the FDA adverse event reporting system database

Drug-Induced Gynecomastia: Data Mining and Analysis of the FDA Adverse Event Reporting System Database

Patients' Lack of Knowledge on Antibiotic Risks Drives Expectations

A pharmacovigilance study on clinical factors of active vitamin D3 analog-related acute kidney injury using the Japanese Adverse Drug Event Report Database

Promoting Patient Engagement in Adverse Drug Reaction Reporting: A Novel Approach Utilizing Set Induction-Based Skill Questionnaires

Communication Key to Improving Patient Safety

Adverse events associated with the use of radiopharmaceuticals: A prospective study from a tertiary care institute

Disproportionality analysis of amenamevir-induced encephalopathy using the Japanese adverse drug event report database

Audit of risk factors of drug-sensitive, drug-resistant tuberculosis disease, a case-control study of patients registered under NTEP, Gujarat

Mobile phone interventions to improve health outcomes among patients with chronic diseases: an umbrella review and evidence synthesis from 34 meta-analyses

Educate to Reduce Unnecessary Antibiotic Prescriptions

Pharmacovigilance of drug-drug interactions: A pharmacokinetic study on the combined oral administration of lurasidone and clozapine in rats by using LC-MS/MS

El Gobierno abandonó el informe que estudiaba la eficacia de la homeopatía

Clozapine and Respiratory Infection Risk: What to Know

The time to address the antibiotic pipeline and access crisis is now

Insulin Therapy De-Escalation to Fixed-Ratio Combo Safe

Fridays and Snacking Bad for Smart Insulin Pen Adherence

Genetic ancestry in Population Pharmacogenomics unravels distinct geographical patterns related to drug toxicity

Adverse drug reactions and drug-related problems with supportive care medications among the oncological population

Risk of Rhabdomyolysis Associated with Dexmedetomidine Use over the Past 10 Years: Insights from the EudraVigilance Database

Retinal vascular occlusion after COVID-19 vaccination: analysis of the French pharmacovigilance database

Promoting Patient Engagement in Adverse Drug Reaction Reporting: A Novel Approach Utilizing Set Induction-Based Skill Questionnaires

Safety Profile of Mass Administration of Albendazole Among School Children (6-19 Years): A Prospective Active Surveillance Study

ExDDI: Explaining Drug-Drug Interaction Predictions with Natural Language

Analysis of anticholinergic drugs associated with aspiration pneumonia using the Japanese adverse drug event report database: Supplementary insights from a scoping review

Understanding medicine related adverse events in people with multiple long-term conditions and polypharmacy

The Rise of Nanotechnology in Pharmaceutical and Healthcare Packaging: Applications and Future Prospective

Description of clinical pharmacists reported interventions to prevent adverse drug events among patients with cardiovascular disease in Qatar

Pregnancy related adverse events and congenital disorders associated with fluoroquinolones: A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS)

Drug-Associated Acute Kidney Disease: Data From a World Pharmacovigilance Database

Relevance of Pharmacovigilance in Aquatic Animal Medicine. A Perspective from Aquaculture Health Experts Attending a Focus Group Meeting at the EMA

Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation

A real-world pharmacovigilance study of esketamine nasal spray

Analysis of publicly available adverse events reported for pediatric patients treated with Janus kinase inhibitors

Disproportionality Analysis of Osimertinib-related Adverse Events in Elderly Patients Using the Japanese Pharmacovigilance Database

From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy

Safety assessment of basiliximab using real-world adverse event data from the FDA Adverse Event Reporting System Database: A retrospective observational study

Efficacy and safety of an oral complementary medicine combination in people with symptomatic knee osteoarthritis: Protocol for the double-blind, randomized, placebo-controlled ATLAS trial

Leveraging Generative AI for Drug Safety and Pharmacovigilance

A Model for an Academia-Industry Collaboration for Pharmacovigilance and Pharmacoepidemiology

Localization of Pharmaceutical Manufacturing in Sub-Saharan Africa

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database

Informe de inteligencia artificial y medicina: resultados de los médicos españoles

AI in Predicting Adverse Drug Reactions: Enhancing Patient Safety

Increasing Mortality Rates in the US, but Not From COVID-19

Managing Drug-Drug Interactions—So Many Drugs, So Little Evidence

Drug-Drug Interactions and the Clinical Tolerability of Colchicine Among Patients With COVID- 19 A Secondary Analysis of the COLCORONA Randomized Clinical Trial

The role of artificial intelligence in revolutionizing personalized medicine: A comprehensive review of techniques and applications

Generative artificial intelligence and ethical considerations in health care: a scoping review and ethics checklist

Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations

Ecofarmacovigilancia: el efecto de los medicamentos sobre el medio ambiente

Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia. A Randomized Clinical Trial

Suspected Adverse Drug Reactions of Rivaroxaban Reported in the United States Food and Drug Administration Adverse Event Reporting System Database: a pharmacovigilance study

Strategies to enhance risk communication about medicines in Malaysia: a Delphi study among multinational experts

Controlling Prescribing through “Preferred Drug” Targets—The Bavarian Experience

Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials

New Approach Methodologies (NAMs) in Drug Safety Assessment: A Vision of the Future

Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database

Comparative sensitivity of laboratory animals used for preclinical convulsion risk assessment to drug-induced convulsion

Misalignment between the evidence base and Scheme design

Risk of myocardial infarction in users of third generation oral contraceptives

Balancing Efficacy and Tolerability: Assessing Treatment Impact and Side Effects in Prescribing Decisions

Integration and development of veterinary Chinese medicine insight into the development of human Chinese medicine

Safety and Pharmacovigilance in Emergency Research Response

Assessment of drug therapy problems among hypertensive patients at integral institute of medical science and research

Concomitant Administration of Psychotropic and Prostate Cancer Drugs: A Pharmacoepidemiologic Study Using Drug–Drug Interaction Databases

Managing Drug-Drug Interactions and Contraindications with Cephalosporins

Global burden of ADHD medication-associated cardiovascular disease, 1967-2023: A comparative analysis using the WHO pharmacovigilance database

Radio frequency identification technology; A method of analysis of falsified pharmaceutical products: Literature review

Drug-induced liver injury associated with atypical generation antipsychotics from the FDA Adverse Event Reporting System (FAERS)

Off‑label and unapproved pediatric drug utilization: A meta‑analysis

Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs

Drug exposure characteristics and related pregnancy outcomes in pregnant women: an observational cohort study

The impact of emergency medicine pharmacists on medication safety for critically ill patients in the resuscitation area of an emergency department: a pilot study

La importancia de la farmacovigilancia con enfoque en las enfermedades crónico degenerativas más comunes en México

Pancreatitis Associated With Teduglutide: A Disproportionality Analysis via the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

A field-portable technology for illicit drug discrimination via deep learning of hybridized reflectance/fluorescence spectro-scopic fingerprints

The Rising Threat of Counterfeit GLP-1 Receptor Agonists: Implications for Public Health

In Vitro Assessment of Inhibitory Effects of Kinase Inhibitors on CYP2C9, 3A and 1A2: Prediction of Drug-Drug Interaction Risk with Warfarin and Direct Oral Anticoagulants

Global Perspective of the Risks of Falsified and Counterfeit Medicines: A Critical Review of the Literature

Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study

Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis

From Botox Party to Botulism: A Case Report and Public Health Warning on Adulterated Botulinum Toxin Injection

Risk factors of passive suicidal ideation among outpatients in traditional medicine clinics: the case of Korean medicine in South Korea

Risk Factors Associated With Drug-Related Side Effects in Children: A Scoping Review

Real-World Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Database for Asciminib

Pharmacy Accessibility and Social Vulnerability

Why the Rise of This Drug-Resistant Fungus Is Raising International Concern

Which Medications Can Cause Edema?

La AEMPS realizará a partir del 1 de septiembre todas las notificaciones a los laboratorios nacionales de medicamentos a través de la Sede Electrónica

Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions

Oral Contraceptives and the Risk of Psychiatric Side Effects: A Review

Drug-Induced Hair Loss: Analysis of the Food and Drug AdministrationLs Adverse Events Reporting System Database

EMA Warns of Anaphylactic Reactions to MS Drug

Statins: So Misunderstood

Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions

No-Prescription Online Semaglutide Poses Multiple Risks

Boletín sobre Seguridad de Medicamentos de Uso Humano. Mayo de 2024

Is Vaginal Estrogen Safe in Breast Cancer Survivors?

Rates of adverse events of antiretroviral therapy in women living with HIV/AIDS: a systematic review and meta-analysis

Measuring access to essential medicines in the sustainable development goals

Medication Optimization Protocol Efficacy for Geriatric Inpatients. A Randomized Clinical Trial

The incidence of heart attacks and strokes was lower after COVID-19 vaccination than before or without vaccination, according to a new study involving nearly the whole adult population of England.

Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso

Donepezil as a safe alternative treatment after maculo-papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data

The Arduousness of Navigating the Drug Facts Label and Assessing Its Quality While Shopping OTC Drugs Online

Exploiting Question-Answer framework with multiGRU to detect Adverse Drug Reaction on social Media

Risk Factors and Drug Therapy Monitoring in CKD Patients (Chronic Kidney Disease)

Comprehensive analysis of cutaneous adverse drug reactions during hospitalization: unveiling nuanced complexities and ensuring patient safety

Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study

Boletín sobre Productos Sanitarios. Abril-junio de 2024

Boletín sobre Cosméticos, Biocidas AEMPS y Productos de Cuidado Personal. Abril-Junio de 2024

Identifying strategies to improve adverse drug reporting through key informant interviews among community pharmacists in a developing country

Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring

THE DANGER OF ORGANIZED CRIME IN THE AREA OF FALSIFICATION OF MEDICINES AND MEDICAL PRODUCTS (PROFIT VS. RIGHT TO HEALTH)

JURIDICAL STUDY OF REPRESIVE LEGAL PROTECTION AGAINST THE CIRCULATION OF FAKE "PATENT" MEDICINE

Adverse Drug Reactions Related with Antibiotic Medicines in Malawi: A Retrospective Analysis of Prevalence and Associated Factors

Safety assessment of Yasmin: Real-world adverse event analysis using the FAERS database

Adverse drug events in cost-effectiveness models of pharmacological interventions for diabetes, diabetic retinopathy, and diabetic macular edema: a scoping review

Prevalence of cardiovascular drug-related adverse drug reactions consultations in UK primary care: A cross-sectional study

Assessment of self-medication practices and safety profile of medicines utilisation among pregnant women attending antenatal clinics in Freetown, Sierra Leone: a multicentre crosssectional study

8 preguntes que us heu de fer per llegir notícies sobre medicaments

Valoración farmacoterapéutica y reacciones adversas a medicamentos en pacientes ancianos ingresados en Cuidados Intensivos

FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products

Los retos de la fitoingeniería en la industria: efectos secundarios y resistencia a los antibióticos

A Path to Improving Medication Appropriateness in Canada: Canadian Drug Agency Transition Office

Las farmacias centinela notifican 70% de reacciones adversas a medicamentos

A Comparative Analysis of Consumers' Patterns of Reimbursable Medications between Online-only and Community Pharmacies

Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures

Aplicando o raciocínio bayesiano para melhorar a precisão diagnóstica no Departamento de Emergências

Cutaneous Adverse Drug Reactions: Analysis of Reports at the Drugs, Poison Information, and Pharmacovigilance Center (2002 To 2022) at the University of Benin Teaching Hospital

Prospective Analysis of Cutaneous Adverse Drug Reactions Encountered in a Tertiary Care Hospital

Comparison of Adverse Events Following Immunosuppressant Administration for Pediatric Patients With Renal Transplants Categorized by Two-Year Age Increments Using the U.S. Food and Drug Administration Adverse Event Reporting System

Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies

Què passa si prenc un medicament caducat?

Impurities in Active Pharmaceutical Ingredients and Drug Products: A Critical Review

Gestión de riesgo del tratamiento con radioyodo en el cáncer diferenciado de tiroides

Differences between human and artificial/augmented intelligence in medicine

“Protectors gàstrics”: quan són realment necessaris?

Drug exposure and risk factors of maculopathy in tamoxifen users

Taper, Dose Down, Discontinue: The Struggle to Use Less Glucocorticoids

Consider Emergency Contraception for Teens With Acne

WHO Upgrades Carcinogenicity of Talc and Acrylonitrile

Acute Pancreatitis: Five Things to Know

'Don't Screen' for Vitamin D: New Endo Society Guideline

D-Day for Vitamin D Disease-Prevention Guideline?

Systemic Fluoroquinolones Do Not Increase Eye Risk

Top 5 Medications That Can Increase Blood Glucose Levels

Prenatal Cannabis Use and Maternal Pregnancy Outcomes

Los agonistas del receptor del péptido 1 similar al glucagón no aumentan el riesgo neurológico ni psiquiátrico

Consider Risks, Toxicity of Some Topical Ingredients in Infants, Young Children

Medications for Obesity. A Review

Canadian Pharmacies Emerge As 'First Stop' for Primary Care

New Benzoyl Peroxide Data Reassuring: Everyday Use Appears Safe

WHO Warns of Counterfeit Ozempic in the Global Supply Chain—Here’s What to Know

Access and Safety—The FDA Drug Approval Conundrum

Seven in ten pharmacists say medicines shortages have put patients at risk in past six months

Disease Awareness and Prescription Drug Communications on Television: Evidence for Conflation and Misleading Product Impressions

Advances in Clinical Pharmacogenomics and Prevention of Severe Cutaneous Adverse Drug Reactions in the Era of Precision Medicine

Knowledge, Attitude & Practice of Pharmacovigilance among Health Care Professionals & Medical Students in North India

4 waves of NLP techniques and how to stitch them together

Los pacientes toman protagonismo tras los nuevos cambios de la legislación farmacéutica de la UE

Los farmacéuticos de AP, actores clave en el nuevo sistema madrileño de ayuda en la receta de medicamentos

Study: Unexpected Safety Signals Identified for Semaglutide in Diabetes, Obesity

Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database

US Fentanyl Seizures Skyrocket

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review

Advancing medical imaging: detecting polypharmacy and adverse drug effects with Graph Convolutional Networks (GCN)

Over-the-counter sales of antibiotics: a call to action to ensure access and prevent excess

National pharmacovigilance of seasonal influenza vaccines in Australia

Aspect-based drug review classification through a hybrid model with ant colony optimization using deep learning

Ensuring Quality Medicine is not a Single Event Rather Combine Effects of a Pharmaceutical Company

Spectrum of psychiatric adverse reactions to cyclin‐dependent kinases 4/6 inhibitors: A pharmacovigilance analysis of the FDA adverse event reporting system

Genotoxicity and acute toxicity of Hyunburikyung-tang: assessing the safety of prescribing traditional Korean medicine for dysmenorrhea

Incidence of drug-resistant pathogens in community-acquired pneumonia at a safety net hospital

Risk factors for drug hypersensitivity reactions in children

The continuing challenge of drug recalls: Insights from a ten-year FDA data analysis

Assessing the impact of regulations on malaria medication supplies in Africa: A literature review

Los médicos de AP alaban el sistema de alerta sobre posibles riesgos de la prescripción de fármacos

Adverse Events of PD-1, PD-L1, CTLA-4, and LAG-3 Immune Checkpoint Inhibitors: An Analysis of the FDA Adverse Events Database

Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study

Más de la mitad de los conductores muertos en 2023 tomaron alcohol, drogas o psicofármacos

Immune-Related Adverse Events Associated with Atezolizumab: Insights from Real-World Pharmacovigilance Data

Revocar la venta de un fármaco porque no hace nada: el extraño caso del Ocaliva que confunde a los médicos

Ancash: Incautan medicamentos de dudosa procedencia

Most Potentially Hepatotoxic Meds Revealed: Real-World Data Analysis

CDC Investigates More Illnesses Linked to Suspected Counterfeit Botulinum Toxin

GLP-1s Don't Increase Neurologic, Psychiatric Risk

Nuevo sistema de notificación en la Unidad de Farmacovigilancia

Evaluation of the Effectiveness of the Adverse Drug Reaction Alert Card System in Preventing the Recurrence of Adverse Drug Reactions

Vigilancia histórica: Cofepris ha dado a conocer 194 distribuidores irregulares de medicamentos

Un estudio desvela que el popular fármaco para adelgazar provoca embarazos inesperados

Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1967 to 2023

Bloodstream infections due to multi-drug resistant bacteria in the emergency department: prevalence, risk factors and outcomes—a retrospective observational study

Factors Determining Quality of Drug Information by Hospital Pharmacies—Results from Five-Year Annual Quality Assessment

Best Practices: Managing Opioid Risks in Older Adults

Lesión hepática inducida por consumo de Valeriana officinalis y Passiflora incarnata, reporte de caso

AN OVERVIEW ON OTC MEDICATION SAFETY: EDUCATION AND RISK MITIGATION

An IoT Intelligent Approach for Safety and Efficiency of Robotic Medicine Delivery in Hospitals

Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey

Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018–2021: A Qualitative Analysis of Industry‐Sponsored Post-Authorization Safety Studies

Big data analytics in the field of multifaceted analyses: A study on “health care management”

Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes

CertificaPROA en el contexto de la resistencia antimicrobiana

Best Practices: Managing Opioid Risks in Older Adults

Pharmacovigilance: Ensuring Drug Safety and Efficacy

Knowledge, attitude and practice (KAP) on food-drug interaction (FDI) among pharmacists working in government health facilities in Sabah, Malaysia

The Biden Administration’s Push to Lower Drug Prices Through March-In Rights

Notes from the Field: Illnesses After Administration of Presumed Counterfeit Botulinum Toxin in Nonmedical Settings — Tennessee and New York City, March 2024

Boletín sobre Seguridad de Medicamentos de Uso Humano. Mayo de 2024

Fraud Involving ADHD Drugs Prompts CDC Warning About Injury, Overdose

Are adverse events higher among patients with acute optic neuritis prescribed glucocorticoids? A retrospective, longitudinal cohort study

The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System

A REVIEW ON PHARMACOVIGILANCE AND DRUG SAFETY MEASURES

Cutaneous Adverse Drug Reactions – B

Cutaneous Adverse Drug Reactions – Part A

Clinical and economic impact of medication administration errors among neonates in neonatal intensive care units

The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System

Sustainable access to effective antibiotics

Patient safety commissioner: “A relentless focus on NHS finance and productivity is failing patient safety”

La Comunidad de Madrid refuerza la seguridad de pacientes y profesionales con un nuevo sistema en la receta de medicamentos

Prescribe with Confidence. Patients with Opioid Use Disorder Need You

EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna

Building a framework for fake news detection in the health domain

A COMPREHENSIVE OVERVIEW ADVANCEMENTS IN PHARMACOVIGILANCE AND HERBAL DRUG DEVELOPMENT

Assessment of medication access and distribution in Nigeria: Challenges and opportunities for improvement

An overview of Albanian Pharmacovigilance System and its harmonization with the European Pharmacovigilance Legislation

Knowledge Graphs in Pharmacovigilance: A Scoping Review

A brief review on pharmacovigilance

Medication errors in older patients: a pharmacovigilance perspective

La AEMPS informa sobre la modificación de los reglamentos de productos sanitarios

The Role of Patient-Reported Outcomes to Measure Treatment Satisfaction in Drug Development

Stakeholder perspectives on the need for professional education and competence in pharmacovigilance in Zambia: A cross-sectional survey

Drug use survey to identify significant drug–drug interactions and assess clinical importance in the outpatient setting of a tertiary care hospital

Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis

Efficacy and safety of chloroquine plus primaquine for the treatment of Plasmodium vivax malaria in Hamusit site, Northwestern Ethiopia

Update on the effect of dental general anaesthesia on neurocognition in children

A COMPARATIVE ANALYSIS OF OFFLINE AND ONLINE ADVERSE DRUG REACTION REPORTING: EFFICIENCY, ACCURACY, AND HEALTHCARE PROFESSIONAL ENGAGEMENT

A multicentric, hospital survey to evaluate the possible adverse drug reactions associated with thyroid medication

Qué es el talco y por qué la OMS lo ha declarado como un producto “probablemente cancerígeno”

ACETAMINOPHEN-INDUCED TOXIC EPIDERMAL NECROLYSIS IN PEDIATRIC PATIENTS-A CASE SERIES

Transatlantic Regulatory Divergence in Pharmaceuticals

PARP inhibitor-related acute renal failure: a real-world study based on the FDA adverse event reporting system database

Study backs RSV vaccine safety during pregnancy

Farmacéuticos salvavidas: bloqueo cautelar y diálogo entre especialistas, claves para la salud del paciente

La AEMPS notifica 42.333 sospechas de reacciones adversas a medicamentos en 2023

La AEMPS publica el Informe Anual del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano

Exploring the Relationship Between Atorvastatin and Memory Loss: A Comprehensive Analysis Integrating Real-World Pharmacovigilance and Mendelian Randomization

Revisión narrativa: las incompatibilidades farmacológicas ¿son prevenibles? Análisis de enfermería

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Current state and novel outlook on prevention and treatment of rising antibiotic resistance in urinary tract infections

Assessing the knowledge, attitude, and practice of hospital-based pharmacists in reporting adverse drug reactions in Lagos, Nigeria

The ethics of artificial intelligence systems in healthcare and medicine: from a local to a global perspective, and back